Home > Riviste > Minerva Endocrinologica > Fascicoli precedenti > Minerva Endocrinologica 2016 March;41(1) > Minerva Endocrinologica 2016 March;41(1):122-37





Rivista sulle Malattie del Sistema Endocrino

Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,118




Minerva Endocrinologica 2016 March;41(1):122-37

lingua: Inglese

Pre-existing diabetes in pregnancy

Suja PADMANABHAN 1, 2, Monica ZEN 3, Vincent LEE 2, 4, 5, Ngai W. CHEUNG 1, 2

1 Department of Diabetes and Endocrinology, Westmead Hospital, Sydney, Australia; 2 School of Medicine, University of Sydney, Sydney, Australia; 3 Department of Obstetrics and Gynecology, Westmead Hospital, Sydney, Australia; 4 Department of Renal Medicine, Westmead Hospital, Sydney, Australia; 5 Centre for Transplant and Renal Research, Westmead Millennium Institute, Sydney, Australia


The incidence of type 1 and type 2 diabetes amongst women of reproductive age is increasing worldwide. Despite recent advances in treatment options for diabetes outside of pregnancy, women still have a significantly increased risk of adverse obstetric outcomes including perinatal death and congenital malformation, compared to the non-diabetic population. An understanding of the physiological changes during pregnancy, management, early detection and prevention of complications and pre-pregnancy care, specific to women with pre-existing diabetes, is important in improving health outcomes in this growing group of women. This review particularly focuses on areas where there have been recent developments or controversy.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail